• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

suction

  1. Medela US - Horrible Company

    Is it just me or has Medela become a company it's founding father would cringe to know about. Ollie is probably up in heaven wondering where he went wrong! The company is in decline and will continue to be until Leadership is replaced. MG is the worst of the lot. Maybe because she has...